Alongside the benefits, a few of the common turoctocog alfa adverse effects would be injection site reaction, [[pyrexia]] and augmented liver enzyme levels. Rare cases of allergic reactions have been reported as well. There is a possibility of patients developing hypersensitivity to the drug since it contains traces of hamster proteins. Activity-neutralising antibodies may be developed whereby expected plasma factor VIII activity levels may not be achieved and thus the bleeding would not be controlled as needed.<ref name="FDA Approval Document"/>
